Author:
Fernández-Prada María,Pérez-Martín Jaime Jesús,Cienfuegos-González Paula
Reference5 articles.
1. Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data;Dey;RMD Open.,2022
2. Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: a systematic review and meta-analysis of 1429 patients;Müller;Vaccine.,2022
3. Consejo Interterritorial. Sistema Nacional de Salud. Recomendaciones de utilización de Evusheld para la prevención de COVID-19 [accessed 10 Oct 2022]. Available from: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Recomendaciones_uso_Evusheld.pdf.
4. Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters;Conte;Mult Scler Relat Disord.,2022
5. Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study;Birabaharan;Clin Infect Dis.,2022